Key Points
- Mannatech director Larry Jobe bought 2,803 shares on May 20 at an average price of $4.12, a purchase worth about $11,548. The transaction increased his holdings by 4.17% to 70,000 shares.
- MTEX shares rose 11.9% and opened at $4.42 on Friday, though the stock remains far below its 52-week high of $12.45. The company has a small market cap of about $8.53 million.
- Mannatech’s latest quarter showed earnings of $0.49 per share on revenue of $24.92 million, but profitability remained weak with a negative net margin and negative return on equity.
Mannatech, Incorporated (NASDAQ:MTEX - Get Free Report) Director Larry Jobe acquired 2,803 shares of the business's stock in a transaction that occurred on Wednesday, May 20th. The shares were purchased at an average cost of $4.12 per share, with a total value of $11,548.36. Following the transaction, the director directly owned 70,000 shares of the company's stock, valued at $288,400. This trade represents a 4.17% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Mannatech Trading Up 11.9%
MTEX opened at $4.42 on Friday. Mannatech, Incorporated has a twelve month low of $3.80 and a twelve month high of $12.45. The company has a 50-day simple moving average of $5.52 and a 200 day simple moving average of $7.24. The company has a quick ratio of 0.59, a current ratio of 1.09 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $8.53 million, a price-to-earnings ratio of -0.66 and a beta of 0.61.
Mannatech (NASDAQ:MTEX - Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.49 earnings per share for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%. The business had revenue of $24.92 million during the quarter.
About Mannatech
(
Get Free Report)
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company's core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company's product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
